CI Ye.Ye.Karabelesh Kherson City Clinical Hosp.

Kherson 73000

0 studies enrolling now · 2 studies all time

What they study most

Crohn's Disease, Dyslipidemia, Type2 Diabetes

Studies at this site

• Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT) — Stopped early
• A Six Week Efficacy, Safety and Tolerability Study of V565 in Crohn's Disease — Completed